NCT04631393 (PACSPI-1) is a clinical trial of Propofol Alfentanil in Pain, sponsored by Stefanie Seifert.

Who is sponsoring NCT04631393?

NCT04631393 is sponsored by Stefanie Seifert.

What drugs are being tested in NCT04631393?

Interventions in NCT04631393: Propofol Alfentanil.

What condition does NCT04631393 study?

NCT04631393 studies Pain, Patient Satisfaction.

Is NCT04631393 still recruiting?

NCT04631393 is currently completed. Last updated 19 October 2021.

Last reviewed 2021-10-19 · How we verify

NCT04631393: PACSPI-1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patient-controlled Sedation in Port Implantation (PACSPI-1)

Completed Last updated 19 October 2021

What this trial tests

trial testing Propofol Alfentanil in Pain in 40 participants. Completed in 15 October 2021.

Timeline

14 April 2021

Primary endpoint
15 October 2021

15 October 2021

Quick facts

Lead sponsor	Stefanie Seifert
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	14 April 2021
Primary completion	15 October 2021
Estimated completion	15 October 2021
Sites	1 location across Sweden

Drugs / interventions tested

Propofol Alfentanil

Conditions studied

Pain — all drugs for Pain →
Patient Satisfaction — all drugs for Patient Satisfaction →

Sponsor

Stefanie Seifert

Who can join

Adults 18 to 105, any sex, with Pain or Patient Satisfaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this prospective, observational study is to assess the feasibility of patient-controlled sedation (PCS) for implantation of subcutaneous venous ports (SVP).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Patient-Controlled Sedation in Port Implantation (PACSPI 1) - A feasibility trial.
Seifert S, Taxbro K, Hammarskjöld F. · · 2022 · cited 2× · PMID 37588584 · DOI 10.1016/j.bjao.2022.100026
Patient-Controlled Sedation in Port Implantation (PACSPI 1) – a Feasibility Trial
Seifert S, Taxbro K, Hammarskjöld F. · · 2022 · DOI 10.21203/rs.3.rs-1305841/v1

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04631393 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stefanie Seifert
Last refreshed: 19 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04631393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing